Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.932 EUR | -0.31% | +1.15% | -15.72% |
Apr. 24 | CapMan to Sell Special Transport Group Havator | MT |
Apr. 15 | Faron Pharmaceuticals reappoints former finance chief on interim basis | AN |
Sales 2024 * | 70.3M 75.39M | Sales 2025 * | 79.47M 85.22M | Capitalization | 342M 367M |
---|---|---|---|---|---|
Net income 2024 * | 22M 23.59M | Net income 2025 * | 33M 35.39M | EV / Sales 2024 * | 5.58 x |
Net Debt 2024 * | 50.17M 53.79M | Net Debt 2025 * | 37.83M 40.57M | EV / Sales 2025 * | 4.78 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
9.87
x | Employees | 200 |
Yield 2024 * |
5.85% | Yield 2025 * |
7.91% | Free-Float | 65.89% |
Latest transcript on CapMan Oyj
1 day | +0.62% | ||
1 week | +1.57% | ||
Current month | +0.10% | ||
1 month | +0.52% | ||
3 months | -13.48% | ||
6 months | -13.29% | ||
Current year | -15.37% |
Managers | Title | Age | Since |
---|---|---|---|
Pia Kåll
CEO | Chief Executive Officer | 44 | 23-03-14 |
Joakim Frimodig
CHM | Chairman | 46 | 15-12-31 |
Atte Rissanen
DFI | Director of Finance/CFO | 37 | 16-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Johan Bygge
BRD | Director/Board Member | 68 | 21-03-16 |
Director/Board Member | 67 | 19-03-12 | |
Director/Board Member | 58 | 93-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 1.93 | -0.41% | 60 787 |
24-04-24 | 1.938 | +0.62% | 82,116 |
24-04-23 | 1.926 | +0.73% | 77,449 |
24-04-22 | 1.912 | +0.84% | 52,029 |
24-04-19 | 1.896 | -0.63% | 102,211 |
Delayed Quote Nasdaq Helsinki, April 24, 2024 at 11:29 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.37% | 366M | |
-1.44% | 33.98B | |
+2.39% | 31.77B | |
+7.26% | 5.57B | |
+0.52% | 3.11B | |
+13.05% | 2.93B | |
+21.17% | 2.86B | |
-18.77% | 2.24B | |
+4.02% | 1.24B | |
-2.11% | 1.07B |
- Stock Market
- Equities
- CAPMAN Stock